Cargando…

1087 Immunogenicity and Safety of 3-Dose Primary Vaccination with Combined DTPa-HBV-IPV/Hib Vaccine in Canadian Aboriginal and non-Aboriginal Infants

Detalles Bibliográficos
Autores principales: Scheifele, David W., Ferguson, Murdo, Predy, Gerald, Dawar, Meena, Assudani, Deepak, Kuriyakose, Sherine, Van Der Meeren, Olivier, Han, Htay Htay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781703/
http://dx.doi.org/10.1093/ofid/ofu052.795
_version_ 1783295018216194048
author Scheifele, David W.
Ferguson, Murdo
Predy, Gerald
Dawar, Meena
Assudani, Deepak
Kuriyakose, Sherine
Van Der Meeren, Olivier
Han, Htay Htay
author_facet Scheifele, David W.
Ferguson, Murdo
Predy, Gerald
Dawar, Meena
Assudani, Deepak
Kuriyakose, Sherine
Van Der Meeren, Olivier
Han, Htay Htay
author_sort Scheifele, David W.
collection PubMed
description
format Online
Article
Text
id pubmed-5781703
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-57817032018-03-01 1087 Immunogenicity and Safety of 3-Dose Primary Vaccination with Combined DTPa-HBV-IPV/Hib Vaccine in Canadian Aboriginal and non-Aboriginal Infants Scheifele, David W. Ferguson, Murdo Predy, Gerald Dawar, Meena Assudani, Deepak Kuriyakose, Sherine Van Der Meeren, Olivier Han, Htay Htay Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5781703/ http://dx.doi.org/10.1093/ofid/ofu052.795 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America
spellingShingle IDWeek 2014 Abstracts
Scheifele, David W.
Ferguson, Murdo
Predy, Gerald
Dawar, Meena
Assudani, Deepak
Kuriyakose, Sherine
Van Der Meeren, Olivier
Han, Htay Htay
1087 Immunogenicity and Safety of 3-Dose Primary Vaccination with Combined DTPa-HBV-IPV/Hib Vaccine in Canadian Aboriginal and non-Aboriginal Infants
title 1087 Immunogenicity and Safety of 3-Dose Primary Vaccination with Combined DTPa-HBV-IPV/Hib Vaccine in Canadian Aboriginal and non-Aboriginal Infants
title_full 1087 Immunogenicity and Safety of 3-Dose Primary Vaccination with Combined DTPa-HBV-IPV/Hib Vaccine in Canadian Aboriginal and non-Aboriginal Infants
title_fullStr 1087 Immunogenicity and Safety of 3-Dose Primary Vaccination with Combined DTPa-HBV-IPV/Hib Vaccine in Canadian Aboriginal and non-Aboriginal Infants
title_full_unstemmed 1087 Immunogenicity and Safety of 3-Dose Primary Vaccination with Combined DTPa-HBV-IPV/Hib Vaccine in Canadian Aboriginal and non-Aboriginal Infants
title_short 1087 Immunogenicity and Safety of 3-Dose Primary Vaccination with Combined DTPa-HBV-IPV/Hib Vaccine in Canadian Aboriginal and non-Aboriginal Infants
title_sort 1087 immunogenicity and safety of 3-dose primary vaccination with combined dtpa-hbv-ipv/hib vaccine in canadian aboriginal and non-aboriginal infants
topic IDWeek 2014 Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781703/
http://dx.doi.org/10.1093/ofid/ofu052.795
work_keys_str_mv AT scheifeledavidw 1087immunogenicityandsafetyof3doseprimaryvaccinationwithcombineddtpahbvipvhibvaccineincanadianaboriginalandnonaboriginalinfants
AT fergusonmurdo 1087immunogenicityandsafetyof3doseprimaryvaccinationwithcombineddtpahbvipvhibvaccineincanadianaboriginalandnonaboriginalinfants
AT predygerald 1087immunogenicityandsafetyof3doseprimaryvaccinationwithcombineddtpahbvipvhibvaccineincanadianaboriginalandnonaboriginalinfants
AT dawarmeena 1087immunogenicityandsafetyof3doseprimaryvaccinationwithcombineddtpahbvipvhibvaccineincanadianaboriginalandnonaboriginalinfants
AT assudanideepak 1087immunogenicityandsafetyof3doseprimaryvaccinationwithcombineddtpahbvipvhibvaccineincanadianaboriginalandnonaboriginalinfants
AT kuriyakosesherine 1087immunogenicityandsafetyof3doseprimaryvaccinationwithcombineddtpahbvipvhibvaccineincanadianaboriginalandnonaboriginalinfants
AT vandermeerenolivier 1087immunogenicityandsafetyof3doseprimaryvaccinationwithcombineddtpahbvipvhibvaccineincanadianaboriginalandnonaboriginalinfants
AT hanhtayhtay 1087immunogenicityandsafetyof3doseprimaryvaccinationwithcombineddtpahbvipvhibvaccineincanadianaboriginalandnonaboriginalinfants